News And Media
Stay In The Know
Qu Biologics’ Site Specific Immunomodulator Enables CAR T-cell Cancer Efficacy in Solid Tumor
17 December 2024
Qu Biologics Inc. is pleased to report exciting survival data using a combination of Qu Biologics’ ...
Soaring Beyond the Bounds of Her Illness
21 July 2023
Since the age of 19, Arifah has observed a persistent dissimilarity between her two legs, with her l ...
Zero-G Wells: Taking mechanobiology into space
10 February 2023
Humanity has always looked to the stars to wonder what lies beyond our planet. But space is also dar ...
NUS researchers improve CAR-T cell therapy for solid tumours through inhibition of conventional signalling pathway
4 February 2023
In the context of Chimeric Antigen Receptor-expressing T cell (CAR-T) therapy for cancer, researcher ...
NUS Medicine and CNA developed documentaries about the School’s Translational Research Programmes
26 November 2022
NUS Medicine, in partnership with Channel NewsAsia, has developed a series of four documentaries on ...
S1P transporter could be crucial in the development of therapeutics for the treatment of Multiple Sclerosis
10 November 2022
Multiple sclerosis (MS) is an autoimmune disease affecting the brain and spinal cord. In MS, the act ...
A fat molecule found to be critical for blood vessel health
18 August 2022
According to the World Health Organization, 15 million people suffer from a stroke each year. Around ...
IRF3 inhibits development of obesity and type 2 diabetes
10 September 2021
The global epidemic of obesity poses a major public health concern. Obesity, characterised by expans ...